Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acetazolamide Versus Dapagliflozin in Acute Decompensated Heart Failure Patients

NCT06535529 is registered in ClinicalTrials.gov with Helwan University as lead sponsor.

NCT NCT06535529
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06535529 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acetazolamide Versus Dapagliflozin in Acute Decompensated Heart Failure Patients
Lead sponsor
Helwan University
Phase
Phase 3
Overall status
Recruiting
Start date
August 24, 2024
Completion date
September 1, 2025
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute decompensated heart failure